Cas:1076197-41-5 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate manufacturer & supplier

Chemical Name:1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate

CAS.NO:1076197-41-5

Synonyms:1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate

Molecular Formula:C₁₉H₁₉NO₃

Molecular Weight:309.35900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:51.32000

Exact Mass:309.13600

LogP:4.37100

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate Use and application,1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate technical grade,usp/ep/jp grade.

Related News: GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate manufacturer After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate supplier Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate vendor After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate factory Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.